In a filing, Adaptive Biotechnologies Corp revealed its Chief Scientific Officer ROBINS HARLAN S unloaded Company’s shares for reported $0.16 million on Jan 06 ’26. In the deal valued at $16.44 per share,10,000 shares were sold. As a result of this transaction, ROBINS HARLAN S now holds 1,222,312 shares worth roughly $19.26 million.
Then, ROBINS CHAD M sold 124,998 shares, generating $1,948,719 in total proceeds. Upon selling the shares at $15.59, the CEO and Chairman now owns 2,584,243 shares.
Before that, LO FRANCIS sold 3,125 shares. Adaptive Biotechnologies Corp shares valued at $50,250 were divested by the Chief People Officer at a price of $16.08 per share. As a result of the transaction, LO FRANCIS now holds 315,978 shares, worth roughly $4.98 million.
A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Craig Hallum began covering ADPT with “Buy” recommendation on June 18, 2025. Goldman revised its rating on March 21, 2025. It rated ADPT as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ADPT
On Monday, Adaptive Biotechnologies Corp [NASDAQ:ADPT] saw its stock fall -1.25% to $15.76. Over the last five days, the stock has lost -0.94%. Adaptive Biotechnologies Corp shares have risen nearly 121.97% since the year began. Nevertheless, the stocks have fallen -2.96% over the past one year.
How much short interest is there in Adaptive Biotechnologies Corp?
A steep rise in short interest was recorded in Adaptive Biotechnologies Corp stocks on 2025-12-15, dropping by -0.63 million shares to a total of 9.74 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 10.37 million shares. There was a decline of -6.42%, which implies that there is a negative sentiment for the stock.
